| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
296,250,000 |
| Market
Cap: |
561.39(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.86 - $4.49 |
|
| Level
I Sector: |
Energy |
| Level
II Sector: |
Energy |
| Level
III Sector: |
Independent Oil & Gas |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile TherapeuticsMD is a women's healthcare company focused on creating and commercializing products to support the lifespan of women from pregnancy prevention through menopause. Co.'s solutions range from contraceptive to bio-identical hormone therapy pharmaceutical products for the treatment of vasomotor symptoms and dyspareunia. Co.'s contraceptive product consist of ANNOVERA (segesterone acetate and ethinyl estradiol vaginal system) a reversible prescription contraceptive that can prevent pregnancy. Co.'s menopause portfolio includes IMVEXXY (estradiol vaginal inserts) for the treatment of dyspareunia; and BIJUVA (estradiol and progesterone) capsules for the treatment of vasomotor symptoms.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
711,818 |
| Total Buy Value |
$0 |
$0 |
$0 |
$29,673,332 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
9 |
| Total Shares Sold |
0 |
19,050 |
19,050 |
60,493 |
| Total Sell Value |
$0 |
$43,683 |
$43,683 |
$38,762,036 |
| Total People Sold |
0 |
1 |
1 |
6 |
| Total Sell Transactions |
0 |
2 |
2 |
15 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Walker Marlan D |
General Counsel |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
50,500 |
50,500 |
|
- |
|
| Borkowski Edward |
EVP, Operations |
• – – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
103,500 |
103,500 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2021-05-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
158,334 |
18,059,334 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2021-03-05 |
4 |
GD |
$0.00 |
$0 |
D/D |
350,000 |
18,201,000 |
|
- |
|
| Milligan John C.k. Iv |
President/Secretary |
• – – |
2021-03-04 |
4 |
D |
$1.46 |
$43,747 |
D/D |
(29,964) |
1,693,455 |
|
- |
|
| Milligan John C.k. Iv |
President/Secretary |
• – – |
2021-03-04 |
4 |
OE |
$0.24 |
$43,748 |
D/D |
179,000 |
1,723,419 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2021-03-04 |
4 |
D |
$1.46 |
$43,747 |
D/D |
(29,964) |
18,551,000 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2021-03-04 |
4 |
OE |
$0.24 |
$43,748 |
D/D |
179,000 |
18,580,964 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2020-06-09 |
4 |
B |
$1.41 |
$66,360 |
D/D |
46,000 |
18,401,964 |
2.81 |
15% |
|
| Collins Cooper C. |
Director |
– • – |
2020-06-09 |
4 |
B |
$1.45 |
$68,875 |
D/D |
47,500 |
140,000 |
2.39 |
15% |
|
| Collins Cooper C. |
Director |
– • – |
2020-06-08 |
4 |
B |
$1.45 |
$38,425 |
D/D |
26,500 |
92,500 |
2.39 |
8% |
|
| Milligan John C.k. Iv |
President/Secretary |
• – – |
2020-06-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
434,814 |
0 |
|
- |
|
| Finizio Robert G |
CEO |
• • – |
2020-06-05 |
4 |
B |
$1.15 |
$34,600 |
D/D |
30,000 |
18,355,964 |
2.81 |
39% |
|
| Thompson Tommy G |
Director |
– • – |
2020-06-04 |
4 |
B |
$1.13 |
$9,831 |
I/I |
8,700 |
699,600 |
2.1 |
46% |
|
| Bisaro Paul |
Director |
– • – |
2020-06-04 |
4 |
B |
$1.14 |
$57,000 |
D/D |
50,000 |
50,000 |
2.39 |
46% |
|
| Finizio Robert G |
CEO |
• • – |
2020-02-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
300,000 |
17,901,000 |
|
- |
|
| Krassan Mitchell |
Chief Strategy Officer |
• – – |
2020-02-03 |
4 |
AS |
$2.26 |
$676,920 |
D/D |
(300,000) |
0 |
|
-39% |
|
| Krassan Mitchell |
Chief Strategy Officer |
• – – |
2020-02-03 |
4 |
OE |
$0.19 |
$59,387 |
D/D |
300,000 |
300,000 |
|
- |
|
| Bernick Brian |
Director |
– • – |
2019-10-25 |
4 |
B |
$2.75 |
$99,000 |
D/D |
36,000 |
98,000 |
2.39 |
- |
|
| Milligan John C.k. Iv |
President/Secretary |
• • – |
2019-10-25 |
4 |
B |
$2.75 |
$198,000 |
D/D |
72,000 |
1,544,419 |
2.81 |
- |
|
| Finizio Robert G |
CEO |
• • – |
2019-10-25 |
4 |
B |
$2.75 |
$198,000 |
D/D |
72,000 |
18,325,964 |
2.81 |
- |
|
| Russell Angus C. |
Director |
– • – |
2019-08-23 |
4 |
B |
$2.77 |
$27,700 |
D/D |
10,000 |
93,500 |
2.39 |
- |
|
| Finizio Robert G |
CEO |
• • – |
2019-08-20 |
4 |
B |
$2.74 |
$95,900 |
D/D |
35,000 |
18,253,964 |
2.81 |
- |
|
| Milligan John C.k. Iv |
President/Secretary |
• • – |
2019-08-16 |
4 |
B |
$2.93 |
$29,300 |
I/I |
10,000 |
3,582,373 |
2.66 |
- |
|
| Russell Angus C. |
Director |
– • – |
2019-08-15 |
4 |
B |
$2.99 |
$29,900 |
D/D |
10,000 |
83,500 |
2.39 |
- |
|
247 Records found
|
|
Page 4 of 10 |
|
|
0.01 (0.53%) 
